KIMS Hospitals
🏛️ Hospital Group · 🇮🇳 India

KIMS Hospitals

📍 HQ Hyderabad  ·  3 hospitals facilitated by Ginger

27
Hospitals
8,300+
Beds
25+
Specialities
5
Indian States
Network figures as reported by KIMS Hospitals
1,000 beds Flagship Hospital18 ECMO Machines2021 Stock-Exchange Listing

About KIMS Hospitals

KIMS Hospitals — Krishna Institute of Medical Sciences — has developed a healthcare model that combines extensive hospital capacity with specialised tertiary and quaternary medicine. Its integrated clinical network manages the complete spectrum of patient needs: from preventive assessment and routine hospital care to complex surgery, organ transplantation, advanced critical care and rehabilitation.

The organisation delivers multidisciplinary healthcare through hospitals, specialised institutes, diagnostic facilities and technology-supported treatment programmes — across cardiac sciences, oncology, neurosciences, gastroenterology, orthopaedics, renal sciences, organ transplantation, robotic surgery, women’s health, paediatrics and emergency medicine.

The network includes a 1,000-bed flagship hospital in Secunderabad — one of India’s largest private hospitals at a single location — one of South Asia’s largest joint-replacement programmes, a major organ-transplantation platform and an ECMO programme supported by 18 machines.

KIMS Hospitals
"To be the most preferred healthcare services brand by providing affordable care and the best clinical outcomes to patients — the KIMS vision"

The KIMS Story

From a 200-bed hospital in Nellore to one of India’s largest corporate hospital groups — built on the idea of taking specialised medicine beyond the largest metropolitan centres, affordably.

2000
First KIMS Hospital, Nellore

The first hospital in the network was established with approximately 200 beds — the foundation of the organisation’s regional healthcare model.

2004
The Secunderabad Flagship

KIMS Secunderabad began with a smaller capacity and expanded progressively into a 1,000-bed tertiary and quaternary institution — still one of India’s largest private hospitals at a single location.

2010
Institutional Investment

Investment from Milestone Private Equity Fund supported organisational development, followed by India Advantage Fund and Emerging India Fund in 2015.

2018
Asia’s First Transcatheter Tricuspid-Valve Replacement

KIMS completed Asia’s first transcatheter tricuspid-valve replacement, strengthening its structural-heart intervention capabilities.

2019
General Atlantic & Strategic Acquisitions

Controlling interests in additional healthcare companies and investment from General Atlantic supported geographic expansion, technology investment and network consolidation.

2020
India’s First COVID Double-Lung Transplant

KIMS performed India’s first double-lung transplant for a patient affected by COVID-19 — demonstrating its capabilities in complex thoracic transplantation and post-operative critical care.

2021
Public Listing & Breathing-Lung Transplantation

KIMS listed on Indian stock exchanges and completed India’s first breathing-lung transplantation using an advanced donor-organ preservation approach.

2022
Multi-State Expansion

Acquisitions, integrations and new hospitals added substantial tertiary and quaternary capacity across additional regions through 2025.

2026
A 27-Hospital Network

KIMS expanded to 27 hospitals and 8,300+ beds across five states — one of India’s largest corporate hospital groups.

scroll for more →

Founder & Leadership

DBB
Dr. B. Bhaskar Rao
Founder, Chairman & Managing Director

A cardiothoracic surgeon who has performed 30,000+ surgeries across a career spanning 25+ years, Dr. Bhaskar Rao began his entrepreneurial journey with a 50-bed cardiovascular centre created to make cardiac surgery more financially accessible. Under his leadership, KIMS developed into a multidisciplinary hospital group focused on tertiary care, advanced technology and affordable treatment.

He also played an important role in the formulation and implementation of the Rajiv Gandhi Aarogyasri healthcare scheme, designed to improve access to hospital treatment for economically disadvantaged patients.

Dr. B. Abhinay Bollineni
Executive Director & CEO

Joining KIMS in 2013 in hospital operations before leading strategy and marketing, Dr. Bollineni became CEO in 2019 — driving network expansion, acquisitions, digital transformation and the 2021 public listing. He was included in Businessworld’s “40 Under 40” list in 2019.

Ms. D. Anitha
Whole-Time Director, Operations

With 16+ years in the hospital sector, Ms. Anitha oversees administration and patient-care services, with a professional background in quality-system auditing and NABH internal quality processes.

Vision, Mission & Core Values

Vision

“To be the most preferred healthcare services brand by providing affordable care and the best clinical outcomes to patients, and to be the best place to work for doctors and employees.”

Mission

Affordable, quality healthcare through patient-centred systems — clinical excellence through modern medical technology, and a culture that encourages doctors to pursue academics and research.

Patient Is Paramount

Patient welfare, safety and treatment outcomes at the centre of every clinical decision — treatment delivered with respect, responsibility and compassion.

Transparency & Integrity

Honest communication and ethical decision-making — helping patients and families understand diagnosis, treatment choices, expected recovery and financial responsibilities.

Compassion

Sincere, courteous and understanding care — recognising that illness affects the emotional and practical well-being of patients and families, not just physical health.

Teamwork — “We, not I”

Complex healthcare requires cooperation among physicians, surgeons, nurses, technicians, rehabilitation specialists and patient-care teams working as one.

Centres of Medical Excellence

Flagship clinical programmes across the KIMS Hospitals network, as described by the group. Browse doctors by specialty below, or ask a Ginger coordinator which centre fits your case.

The Institute of Cardiac Sciences combines preventive, non-invasive and interventional cardiology, electrophysiology, cardiothoracic surgery and structural-heart intervention — angiography, angioplasty, pacemakers, radiofrequency ablation, CABG, valve repair and replacement, TAVR/TAVI, aortic surgery and minimally invasive cardiac surgery.

Surgical treatment for the heart, lungs, chest and major vessels — bypass grafting, aortic and mitral valve replacement, congenital-heart surgery, aneurysm repair, minimally invasive, robotic and thoracic surgery.

Heart, lung, liver, kidney, pancreas, cornea and bone marrow transplantation — living and deceased donor, paediatric and combined-organ programmes, with ex vivo lung perfusion and LVAD support. Home to advanced procedures including COVID-related double-lung and breathing-lung transplantation.

The Institute of Oncological Sciences delivers medical, surgical and radiation oncology, haemato-oncology, bone marrow transplantation, interventional and robotic oncology, paediatric oncology and palliative care — with stereotactic radiosurgery and image-guided radiotherapy.

Neurology, neurosurgery, interventional neurology and neurocritical care — stroke thrombolysis, carotid stenting, brain-tumour and epilepsy surgery, deep-brain stimulation, Gamma Knife radiosurgery, MR-guided focused ultrasound and spine surgery. One of India’s major private-hospital epilepsy programmes.

One of South Asia’s largest joint-replacement programmes — total, partial and revision knee, hip and ankle replacement, robotic joint replacement, arthroscopy, ligament reconstruction, sports injuries, trauma and bone-tumour surgery.

Digestive tract, liver, pancreatic and biliary disease — advanced endoscopy, colonoscopy, ERCP, endoscopic ultrasound, small-bowel enteroscopy, GI and hepatobiliary surgery, and liver transplantation.

Acute kidney injury through kidney failure — haemodialysis, peritoneal dialysis, renal biopsy, critical-care nephrology, continuous renal-replacement therapy and kidney transplantation.

Stones, prostate conditions, incontinence, strictures and urological cancers — endoscopic, laser (including HoLEP), laparoscopic and robotic-assisted surgery, radical prostatectomy and nephron-sparing surgery.

The Institute of Robotic Sciences provides minimally invasive robotic surgery across colorectal, gynaecology, urology, ENT, general, gastrointestinal and cancer surgery — magnified high-definition visualisation with extended instrument motion.

Asthma, COPD, tuberculosis, interstitial lung disease, sleep apnoea, respiratory failure and lung cancer — supported by respiratory intensive care and the KIMS ECMO programme.

A dedicated programme for irreversible heart or lung failure — heart, single-lung, double-lung and combined heart-lung transplantation, ex vivo lung perfusion, LVAD implantation and ECMO support.

Adolescence through menopause — routine and high-risk pregnancy, fertility assessment, IVF and IUI, gynaecological and robotic gynaecological surgery, urogynaecology and gynaecological oncology.

Newborn to adolescent care — NICU, PICU, paediatric emergency, paediatric cardiology and cardiac surgery, neurology, gastroenterology, nephrology, oncology, orthopaedics, urology and paediatric transplantation.

Advanced Medical Procedures

Transcatheter aortic-valve replacement for selected patients with severe aortic-valve narrowing — a replacement valve delivered through a catheter, suitable when open-heart surgery carries higher risk.

Treatment for severe tricuspid-valve disease without conventional open-heart surgery — KIMS completed Asia’s first such procedure in 2018.

For irreversible organ failure beyond medicines and devices — detailed evaluation, donor matching, transplant surgery, intensive-care monitoring, immunosuppressive therapy and long-term rehabilitation.

Advanced life support for severe heart or lung failure — blood is oxygenated outside the body and sent back to the patient. KIMS introduced ECMO in Hyderabad in 2013 and operates a programme supported by 18 machines, including neonatal ECMO.

Replacing diseased blood-forming cells with healthy stem cells — for leukaemia, lymphoma, multiple myeloma, aplastic anaemia, thalassaemia and immune disorders.

Non-invasive, highly focused radiation for selected brain tumours, metastases, arteriovenous malformations and trigeminal neuralgia — no surgical incision.

MRI guidance combined with focused ultrasound energy for selected movement disorders such as essential tremor — incision-free.

Robotic-assisted surgery for selected prostate, colorectal, stomach, cervical, endometrial and head-and-neck cancers — magnified visualisation and precise movement through small incisions.

Radical prostatectomy, partial nephrectomy, kidney-cancer and bladder surgery, and reconstructive procedures with robotic assistance.

Holmium Laser Enucleation of the Prostate — obstructing prostate tissue removed through the urinary passage with a laser, no external incision.

State-of-the-Art Medical Technologies

🤖
4-Arm HD Da Vinci Robotic System

Minimally invasive surgery with magnified high-definition visualisation and articulated instruments — colorectal, gynaecological, urological, ENT and general surgery.

💡
Novalis Tx Linear Accelerator

Advanced radiosurgery and radiotherapy — focused high-energy radiation for selected tumours of the brain, spine, lungs and liver while limiting exposure to healthy structures.

🧲
O-Arm Surgical Imaging

Multidimensional real-time imaging during spine, orthopaedic and trauma surgery — confirming anatomy and implant positioning.

🧲
3-Tesla MRI

Detailed soft-tissue, brain and spine imaging with faster scanning and improved diagnostic detail.

💡
Voluson 4D Pregnancy Ultrasound

Detailed, real-time fetal imaging — assessment of development, movement and selected structural conditions.

Achievements & Accreditations

NABH accreditation (hospitals) and NABH Digital Standards
NABL accreditation for laboratories
American Accreditation Commission International
ISO 9001:2015 certification
Pharmacie De Qualité certification
NABH Emergency Department accreditation
Central Sterile Supply Department certification
Asia’s first transcatheter tricuspid-valve replacement (2018)
India’s first COVID-related double-lung transplant (2020)
India’s first breathing-lung transplantation (2021)
One of South Asia’s largest joint-replacement programmes

International Patient Services

KIMS Hospitals provides coordinated medical and travel assistance for international patients — before arrival, during hospitalisation and after discharge.
1
Before Arrival
Submit medical records, reports & imaging for reviewA patient coordinator connects your reports with the right specialistPreliminary medical opinion & treatment planCost estimate & expected hospital stay
2
During Treatment
Coordinated specialist care across departmentsDiagnostics, treatment & surgeryIntensive care where neededSupport for accompanying family members
3
Discharge & Aftercare
Discharge summary & medical recordsMedication instructions & rehabilitation guidanceFollow-up recommendations & travel adviceTelephone or video follow-up after you are home
🤝
Where Ginger Healthcare fits: we coordinate this entire journey for you at KIMS Hospitals — free treatment-plan guidance, direct hospital liaison, and a single counsellor from first report to follow-up.

KIMS Hospitals — Frequently Asked Questions

How many hospitals does KIMS have?

KIMS reports 27 hospitals with 8,300+ beds across five Indian states, including its 1,000-bed flagship in Secunderabad — one of India’s largest private hospitals at a single location. See the hospital selector at the top of this page.

What is KIMS known for medically?

Asia’s first transcatheter tricuspid-valve replacement, India’s first COVID-related double-lung transplant and first breathing-lung transplantation, one of South Asia’s largest joint-replacement programmes, a major epilepsy programme, and an 18-machine ECMO programme including neonatal ECMO.

Who founded KIMS Hospitals?

Dr. B. Bhaskar Rao, a cardiothoracic surgeon with 30,000+ surgeries, founded KIMS beginning with a 50-bed cardiovascular centre — and remains Chairman and Managing Director. KIMS listed on Indian stock exchanges in 2021.

Is KIMS accredited?

KIMS facilities hold NABH (including Digital Standards and Emergency Department), NABL, American Accreditation Commission International, ISO 9001:2015 and other quality certifications.

Does KIMS treat international patients?

Yes — a dedicated international team reviews medical reports before travel, arranges specialist opinions, treatment plans and cost estimates, coordinates care during hospitalisation and follows up by phone or video after discharge.

How do I get a treatment cost estimate at KIMS?

Share your medical reports with a Ginger Healthcare counsellor — you’ll receive a specialist opinion, a proposed treatment plan, a cost estimate and the expected hospital stay before you travel, free of charge and with no obligation.

📍 HQ: Hyderabad

Your Health Deserves the Best — Not the Most Expensive

Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.

🔒 100% Free🏥 JCI Accredited💬 Counsellors Online🤝 No Obligation